Battling the Bioinvaders

Mosquitoes infected with the West Nile virus fly through American air; green crabs and other foreign crustaceans feed on indigenous sea life in San Francisco Bay; the Formosan termite is feasting on historic New Orleans; and the next boat or plane arriving in the United States from anywhere could be hauling who-knows-what in its ballast waters or cargo hold. Collectively called invasive species, these uninvited animals, insects, flora, and pathogens continue to exacerbate eradication efforts of

Written byJean Mccann
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Collectively called invasive species, these uninvited animals, insects, flora, and pathogens continue to exacerbate eradication efforts of scientists, government officials, business people, and other stakeholders. According to a January report issued by the National Invasive Species Council, the annual battle costs the United States $137 billion a year.1 Between 1961 and 1995, according to the San Francisco Estuary Institute, one new species invaded the bay's ecosystem every 14 weeks, and at least four of them a year became established.

Historically, the federal government has fought a usually divided battle against these foes, with various agencies and departments confronting invaders in their area of expertise. The Centers for Disease Control and Prevention deals with one aspect of West Nile, for example, and the US Department of Agriculture deals with another. About $997 million in federal funds were set aside for the efforts this year.

Whether the Bush administration will adopt such ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies